

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | thyroid gland development (GO:0030878) | 8.65712845 |
| 2 | surfactant homeostasis (GO:0043129) | 6.18576178 |
| 3 | drug transmembrane transport (GO:0006855) | 5.57903615 |
| 4 | urate metabolic process (GO:0046415) | 5.57080351 |
| 5 | phosphate ion transport (GO:0006817) | 5.55975867 |
| 6 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 5.55857445 |
| 7 | chemical homeostasis within a tissue (GO:0048875) | 5.54541887 |
| 8 | cellular response to gonadotropin stimulus (GO:0071371) | 5.01768194 |
| 9 | phosphate ion transmembrane transport (GO:0035435) | 4.96540914 |
| 10 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.95839819 |
| 11 | nephron tubule formation (GO:0072079) | 4.78741926 |
| 12 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 4.77929615 |
| 13 | behavioral response to nicotine (GO:0035095) | 4.73871357 |
| 14 | exogenous drug catabolic process (GO:0042738) | 4.62041683 |
| 15 | drug transport (GO:0015893) | 4.57413328 |
| 16 | phenol-containing compound metabolic process (GO:0018958) | 4.57158769 |
| 17 | drug catabolic process (GO:0042737) | 4.53110176 |
| 18 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 4.44003701 |
| 19 | hydrogen peroxide catabolic process (GO:0042744) | 4.28769822 |
| 20 | hormone biosynthetic process (GO:0042446) | 4.22349783 |
| 21 | organic cation transport (GO:0015695) | 4.16044543 |
| 22 | excretion (GO:0007588) | 4.04564033 |
| 23 | negative regulation of metanephros development (GO:0072217) | 4.03005834 |
| 24 | lysine metabolic process (GO:0006553) | 4.02059303 |
| 25 | lysine catabolic process (GO:0006554) | 4.02059303 |
| 26 | female gonad development (GO:0008585) | 3.84890186 |
| 27 | * sulfate transmembrane transport (GO:1902358) | 3.84566277 |
| 28 | pattern specification involved in kidney development (GO:0061004) | 3.80748983 |
| 29 | metanephric nephron tubule development (GO:0072234) | 3.78870671 |
| 30 | metanephric tubule development (GO:0072170) | 3.78870671 |
| 31 | quaternary ammonium group transport (GO:0015697) | 3.76456450 |
| 32 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 3.75682262 |
| 33 | mesonephros development (GO:0001823) | 3.75444173 |
| 34 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.70937692 |
| 35 | response to mercury ion (GO:0046689) | 3.68838901 |
| 36 | urogenital system development (GO:0001655) | 3.68237889 |
| 37 | cysteine metabolic process (GO:0006534) | 3.64827008 |
| 38 | metanephric nephron epithelium development (GO:0072243) | 3.64007834 |
| 39 | sulfation (GO:0051923) | 3.57195054 |
| 40 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 3.53347587 |
| 41 | positive regulation of metanephros development (GO:0072216) | 3.51107873 |
| 42 | beta-amyloid metabolic process (GO:0050435) | 3.51075307 |
| 43 | cellular potassium ion homeostasis (GO:0030007) | 3.49576128 |
| 44 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.48920279 |
| 45 | short-chain fatty acid metabolic process (GO:0046459) | 3.42080713 |
| 46 | cellular response to ATP (GO:0071318) | 3.40860771 |
| 47 | phosphate ion homeostasis (GO:0055062) | 3.36113685 |
| 48 | trivalent inorganic anion homeostasis (GO:0072506) | 3.36113685 |
| 49 | peptide catabolic process (GO:0043171) | 3.35939632 |
| 50 | * sulfate transport (GO:0008272) | 3.34741643 |
| 51 | gonadal mesoderm development (GO:0007506) | 3.29815166 |
| 52 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.29780587 |
| 53 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.29664310 |
| 54 | sodium-independent organic anion transport (GO:0043252) | 3.27454734 |
| 55 | positive regulation of hormone metabolic process (GO:0032352) | 3.25843625 |
| 56 | metanephric epithelium development (GO:0072207) | 3.25303315 |
| 57 | response to gonadotropin (GO:0034698) | 3.25128721 |
| 58 | lung lobe morphogenesis (GO:0060463) | 3.23148318 |
| 59 | response to xenobiotic stimulus (GO:0009410) | 3.15502925 |
| 60 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 3.11125653 |
| 61 | positive regulation of digestive system process (GO:0060456) | 3.10749850 |
| 62 | positive regulation of fatty acid oxidation (GO:0046321) | 3.09450488 |
| 63 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.08622494 |
| 64 | glutathione biosynthetic process (GO:0006750) | 3.05846886 |
| 65 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.03374475 |
| 66 | homocysteine metabolic process (GO:0050667) | 3.00373955 |
| 67 | thyroid hormone generation (GO:0006590) | 23.0553732 |
| 68 | negative regulation of kidney development (GO:0090185) | 2.99954976 |
| 69 | specification of organ identity (GO:0010092) | 2.97860721 |
| 70 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.96574622 |
| 71 | negative regulation of response to food (GO:0032096) | 2.95998348 |
| 72 | negative regulation of appetite (GO:0032099) | 2.95998348 |
| 73 | vitamin D metabolic process (GO:0042359) | 2.95673872 |
| 74 | glyoxylate metabolic process (GO:0046487) | 2.95568902 |
| 75 | embryonic epithelial tube formation (GO:0001838) | 2.95389815 |
| 76 | membrane repolarization during action potential (GO:0086011) | 2.93949880 |
| 77 | negative regulation of microtubule polymerization (GO:0031115) | 2.93052052 |
| 78 | sodium ion export (GO:0071436) | 2.92906528 |
| 79 | renal absorption (GO:0070293) | 2.91639280 |
| 80 | angiotensin maturation (GO:0002003) | 2.91383573 |
| 81 | atrial cardiac muscle cell action potential (GO:0086014) | 2.89426042 |
| 82 | negative regulation of hormone metabolic process (GO:0032351) | 2.87968759 |
| 83 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.87753248 |
| 84 | embryonic hemopoiesis (GO:0035162) | 2.86288357 |
| 85 | mesenchymal to epithelial transition (GO:0060231) | 2.86282239 |
| 86 | glycoside metabolic process (GO:0016137) | 2.85710609 |
| 87 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.85479954 |
| 88 | cellular ketone body metabolic process (GO:0046950) | 2.82948368 |
| 89 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.81941767 |
| 90 | positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190) | 2.80011899 |
| 91 | hydrogen peroxide metabolic process (GO:0042743) | 2.79599354 |
| 92 | kidney morphogenesis (GO:0060993) | 2.79494498 |
| 93 | aspartate family amino acid catabolic process (GO:0009068) | 2.79030527 |
| 94 | amino-acid betaine transport (GO:0015838) | 2.75804168 |
| 95 | carnitine transport (GO:0015879) | 2.75804168 |
| 96 | epithelial tube formation (GO:0072175) | 2.74105436 |
| 97 | response to parathyroid hormone (GO:0071107) | 2.73852123 |
| 98 | kynurenine metabolic process (GO:0070189) | 2.73791394 |
| 99 | cellular sodium ion homeostasis (GO:0006883) | 2.73022329 |
| 100 | nephron tubule development (GO:0072080) | 2.71281787 |
| 101 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.70846378 |
| 102 | regulation of stem cell maintenance (GO:2000036) | 2.70683193 |
| 103 | cellular modified amino acid catabolic process (GO:0042219) | 2.70380407 |
| 104 | transepithelial transport (GO:0070633) | 2.70098017 |
| 105 | locomotory exploration behavior (GO:0035641) | 2.69717527 |
| 106 | sodium ion homeostasis (GO:0055078) | 2.65706204 |
| 107 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.64806919 |
| 108 | hormone metabolic process (GO:0042445) | 2.63600312 |
| 109 | L-fucose catabolic process (GO:0042355) | 2.62978348 |
| 110 | fucose catabolic process (GO:0019317) | 2.62978348 |
| 111 | L-fucose metabolic process (GO:0042354) | 2.62978348 |
| 112 | sodium ion transport (GO:0006814) | 2.62833543 |
| 113 | lung vasculature development (GO:0060426) | 2.61664350 |
| 114 | flavonoid metabolic process (GO:0009812) | 2.61634726 |
| 115 | toxin transport (GO:1901998) | 2.60214819 |
| 116 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.60165880 |
| 117 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.59772351 |
| 118 | tricarboxylic acid metabolic process (GO:0072350) | 2.59771897 |
| 119 | citrulline biosynthetic process (GO:0019240) | 2.59474219 |
| 120 | ketone body metabolic process (GO:1902224) | 2.58662974 |
| 121 | valine metabolic process (GO:0006573) | 2.57875173 |
| 122 | axoneme assembly (GO:0035082) | 2.57510909 |
| 123 | serotonin metabolic process (GO:0042428) | 2.57067352 |
| 124 | membrane repolarization (GO:0086009) | 2.56570143 |
| 125 | modified amino acid transport (GO:0072337) | 2.55812990 |
| 126 | cAMP catabolic process (GO:0006198) | 2.54283621 |
| 127 | primary amino compound metabolic process (GO:1901160) | 2.53756388 |
| 128 | cell communication by electrical coupling (GO:0010644) | 2.53094054 |
| 129 | 4-hydroxyproline metabolic process (GO:0019471) | 2.52029500 |
| 130 | vocalization behavior (GO:0071625) | 2.51592305 |
| 131 | positive regulation of respiratory burst (GO:0060267) | 2.51098345 |
| 132 | indole-containing compound metabolic process (GO:0042430) | 2.50898280 |
| 133 | indole-containing compound catabolic process (GO:0042436) | 2.50780765 |
| 134 | indolalkylamine catabolic process (GO:0046218) | 2.50780765 |
| 135 | tryptophan catabolic process (GO:0006569) | 2.50780765 |
| 136 | keratinization (GO:0031424) | 2.50500601 |
| 137 | reflex (GO:0060004) | 2.49963616 |
| 138 | vitamin transmembrane transport (GO:0035461) | 2.49104095 |
| 139 | positive regulation of mesonephros development (GO:0061213) | 2.49000067 |
| 140 | indolalkylamine metabolic process (GO:0006586) | 2.47024018 |
| 141 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.46776325 |
| 142 | adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189) | 2.46554261 |
| 143 | regulation of cilium movement (GO:0003352) | 2.45429708 |
| 144 | regulation of energy homeostasis (GO:2000505) | 2.45276022 |
| 145 | protein polyglutamylation (GO:0018095) | 2.44670767 |
| 146 | cochlea development (GO:0090102) | 2.43703029 |
| 147 | synapse assembly (GO:0007416) | 2.43568395 |
| 148 | regulation of metanephros development (GO:0072215) | 2.43557009 |
| 149 | regulation of hippo signaling (GO:0035330) | 2.42899450 |
| 150 | endothelial cell chemotaxis (GO:0035767) | 2.42196182 |
| 151 | neuronal action potential (GO:0019228) | 2.42039107 |
| 152 | cellular response to ammonium ion (GO:0071242) | 2.41639618 |
| 153 | epithelial cilium movement (GO:0003351) | 2.40401788 |
| 154 | negative regulation of blood pressure (GO:0045776) | 2.40148198 |
| 155 | regulation of branching involved in ureteric bud morphogenesis (GO:0090189) | 2.39297983 |
| 156 | regulation of myelination (GO:0031641) | 2.37956169 |
| 157 | gamma-aminobutyric acid transport (GO:0015812) | 2.37635890 |
| 158 | cardiovascular system development (GO:0072358) | 2.37514115 |
| 159 | glutamate receptor signaling pathway (GO:0007215) | 2.37295978 |
| 160 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.36870522 |
| 161 | L-phenylalanine metabolic process (GO:0006558) | 2.36870522 |
| 162 | renal tubule development (GO:0061326) | 2.35938027 |
| 163 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.35627696 |
| 164 | nonmotile primary cilium assembly (GO:0035058) | 2.34518062 |
| 165 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.34438717 |
| 166 | hypotonic response (GO:0006971) | 2.34013119 |
| 167 | fructose metabolic process (GO:0006000) | 2.31958524 |
| 168 | sodium ion transmembrane transport (GO:0035725) | 2.31816909 |
| 169 | branched-chain amino acid metabolic process (GO:0009081) | 2.31807563 |
| 170 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.31521883 |
| 171 | regulation of action potential (GO:0098900) | 2.31293690 |
| 172 | cell volume homeostasis (GO:0006884) | 2.31200026 |
| 173 | complement activation, alternative pathway (GO:0006957) | 2.31129842 |
| 174 | transmission of nerve impulse (GO:0019226) | 2.30975787 |
| 175 | bicarbonate transport (GO:0015701) | 2.30875955 |
| 176 | response to magnesium ion (GO:0032026) | 2.30579923 |
| 177 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.29511535 |
| 178 | L-phenylalanine catabolic process (GO:0006559) | 2.29511535 |
| 179 | nephron epithelium development (GO:0072009) | 2.29400404 |
| 180 | peptide biosynthetic process (GO:0043043) | 2.28724979 |
| 181 | serine family amino acid catabolic process (GO:0009071) | 2.28627517 |
| 182 | cyclic nucleotide catabolic process (GO:0009214) | 2.28619411 |
| 183 | negative regulation of telomere maintenance (GO:0032205) | 2.28313095 |
| 184 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.28239581 |
| 185 | nephron tubule morphogenesis (GO:0072078) | 2.26847813 |
| 186 | nephron epithelium morphogenesis (GO:0072088) | 2.26847813 |
| 187 | exploration behavior (GO:0035640) | 2.26682322 |
| 188 | regulation of acrosome reaction (GO:0060046) | 2.26462577 |
| 189 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.25526383 |
| 190 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 2.20972922 |
| 191 | response to pheromone (GO:0019236) | 2.20851889 |
| 192 | thyroid hormone metabolic process (GO:0042403) | 19.3306758 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.55315984 |
| 2 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.54207724 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.51135238 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 2.47487830 |
| 5 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.35660946 |
| 6 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.19591142 |
| 7 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.15938808 |
| 8 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.14894348 |
| 9 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.13943202 |
| 10 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.02994946 |
| 11 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.02867448 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.01390612 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.01390612 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.98681227 |
| 15 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.95625398 |
| 16 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.94625086 |
| 17 | FUS_26573619_Chip-Seq_HEK293_Human | 1.93456524 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.90887320 |
| 19 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.87167410 |
| 20 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.86790549 |
| 21 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.86585475 |
| 22 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.86509643 |
| 23 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.85776720 |
| 24 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.85422156 |
| 25 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.85101243 |
| 26 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.81521001 |
| 27 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.78913450 |
| 28 | P300_19829295_ChIP-Seq_ESCs_Human | 1.78639422 |
| 29 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.75506614 |
| 30 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.75430680 |
| 31 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.74933245 |
| 32 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.68889567 |
| 33 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.68773485 |
| 34 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.66980161 |
| 35 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.66699470 |
| 36 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.63317695 |
| 37 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.62424328 |
| 38 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.61902560 |
| 39 | EWS_26573619_Chip-Seq_HEK293_Human | 1.61783826 |
| 40 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.59864368 |
| 41 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.59404061 |
| 42 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.58193385 |
| 43 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.56304369 |
| 44 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.55822318 |
| 45 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.52127741 |
| 46 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.51905804 |
| 47 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.51829410 |
| 48 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.51506288 |
| 49 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.50847262 |
| 50 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.49172604 |
| 51 | STAT3_23295773_ChIP-Seq_U87_Human | 1.48685397 |
| 52 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.48624004 |
| 53 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.46965446 |
| 54 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.46019304 |
| 55 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.45841786 |
| 56 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.45793548 |
| 57 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.45568802 |
| 58 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.45451455 |
| 59 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.44626412 |
| 60 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.43793932 |
| 61 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.43418906 |
| 62 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.42614229 |
| 63 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.41849312 |
| 64 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.41560443 |
| 65 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.40666980 |
| 66 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.39672709 |
| 67 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.39672709 |
| 68 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.39324432 |
| 69 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.38040864 |
| 70 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.37369751 |
| 71 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.35149772 |
| 72 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.34119472 |
| 73 | TCF4_23295773_ChIP-Seq_U87_Human | 1.33553265 |
| 74 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.33000804 |
| 75 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.32595382 |
| 76 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.31867894 |
| 77 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.31548370 |
| 78 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30740335 |
| 79 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.30669320 |
| 80 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.30668964 |
| 81 | * EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.30653198 |
| 82 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.30589832 |
| 83 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.29135595 |
| 84 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.27874427 |
| 85 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.27750045 |
| 86 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.27501503 |
| 87 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.27420236 |
| 88 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.26611530 |
| 89 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.25831354 |
| 90 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.25747163 |
| 91 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.25084198 |
| 92 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23504697 |
| 93 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.22905373 |
| 94 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.22895002 |
| 95 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22895002 |
| 96 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.20781383 |
| 97 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.20002697 |
| 98 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.18053523 |
| 99 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.17853871 |
| 100 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.17797196 |
| 101 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.17363085 |
| 102 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.16713520 |
| 103 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.16090164 |
| 104 | RXR_22108803_ChIP-Seq_LS180_Human | 1.15582267 |
| 105 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.15175973 |
| 106 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.13467967 |
| 107 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.13277874 |
| 108 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.13205890 |
| 109 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.13141920 |
| 110 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.13141920 |
| 111 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.11887236 |
| 112 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.11773670 |
| 113 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11744882 |
| 114 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.11559040 |
| 115 | AR_25329375_ChIP-Seq_VCAP_Human | 1.11169980 |
| 116 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.10567609 |
| 117 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.10471402 |
| 118 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.10420670 |
| 119 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.10009410 |
| 120 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.09280040 |
| 121 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.09014001 |
| 122 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.07680251 |
| 123 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.07582269 |
| 124 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.05753437 |
| 125 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.05753437 |
| 126 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.05148545 |
| 127 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.03476342 |
| 128 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.01342962 |
| 129 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.01319856 |
| 130 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.00491629 |
| 131 | KDM2B_26808549_Chip-Seq_K562_Human | 1.00329245 |
| 132 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.00036722 |
| 133 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.00000946 |
| 134 | TP53_16413492_ChIP-PET_HCT116_Human | 0.99956013 |
| 135 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.99666404 |
| 136 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.99453092 |
| 137 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.99453092 |
| 138 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.99144985 |
| 139 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.98136786 |
| 140 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.97199582 |
| 141 | * SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.97197527 |
| 142 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.96632374 |
| 143 | NCOR_22424771_ChIP-Seq_293T_Human | 0.96504603 |
| 144 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.96072294 |
| 145 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.95844362 |
| 146 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.95510229 |
| 147 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.95086418 |
| 148 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.94981722 |
| 149 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.94659274 |
| 150 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93889007 |
| 151 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.93714191 |
| 152 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.91766466 |
| 153 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.90929852 |
| 154 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90534130 |
| 155 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.90188457 |
| 156 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87912858 |
| 157 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.86745289 |
| 158 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.86226379 |
| 159 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.85459664 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 5.98494024 |
| 2 | MP0004043_abnormal_pH_regulation | 4.11426022 |
| 3 | MP0000383_abnormal_hair_follicle | 4.07030485 |
| 4 | MP0005360_urolithiasis | 3.76932512 |
| 5 | * MP0001765_abnormal_ion_homeostasis | 3.74117739 |
| 6 | MP0004019_abnormal_vitamin_homeostasis | 3.44304948 |
| 7 | MP0001958_emphysema | 3.34692602 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 3.05073425 |
| 9 | MP0004859_abnormal_synaptic_plasticity | 3.03603339 |
| 10 | MP0005332_abnormal_amino_acid | 2.78060955 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 2.68166399 |
| 12 | MP0005636_abnormal_mineral_homeostasis | 2.60957244 |
| 13 | * MP0009643_abnormal_urine_homeostasis | 2.50680224 |
| 14 | MP0004782_abnormal_surfactant_physiolog | 2.47210885 |
| 15 | MP0003880_abnormal_central_pattern | 2.46985842 |
| 16 | MP0001756_abnormal_urination | 2.39130919 |
| 17 | MP0010386_abnormal_urinary_bladder | 2.29995250 |
| 18 | MP0008875_abnormal_xenobiotic_pharmacok | 2.22545970 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 2.13273872 |
| 20 | MP0002136_abnormal_kidney_physiology | 2.03055860 |
| 21 | MP0003646_muscle_fatigue | 1.87853626 |
| 22 | MP0000631_abnormal_neuroendocrine_gland | 1.76920855 |
| 23 | * MP0001485_abnormal_pinna_reflex | 1.75118229 |
| 24 | MP0004858_abnormal_nervous_system | 1.71284211 |
| 25 | MP0003329_amyloid_beta_deposits | 1.70699645 |
| 26 | MP0005310_abnormal_salivary_gland | 1.68500505 |
| 27 | MP0003635_abnormal_synaptic_transmissio | 1.64853779 |
| 28 | MP0001440_abnormal_grooming_behavior | 1.63836338 |
| 29 | MP0002272_abnormal_nervous_system | 1.63620928 |
| 30 | MP0005646_abnormal_pituitary_gland | 1.59033765 |
| 31 | MP0005167_abnormal_blood-brain_barrier | 1.58603911 |
| 32 | MP0000538_abnormal_urinary_bladder | 1.58109397 |
| 33 | MP0005058_abnormal_lysosome_morphology | 1.58082515 |
| 34 | MP0002796_impaired_skin_barrier | 1.56523430 |
| 35 | MP0000604_amyloidosis | 1.55433688 |
| 36 | MP0002909_abnormal_adrenal_gland | 1.55047874 |
| 37 | MP0000537_abnormal_urethra_morphology | 1.54280099 |
| 38 | MP0000372_irregular_coat_pigmentation | 1.52597991 |
| 39 | MP0005551_abnormal_eye_electrophysiolog | 1.52374085 |
| 40 | MP0004133_heterotaxia | 1.51347466 |
| 41 | MP0003938_abnormal_ear_development | 1.46675723 |
| 42 | MP0005085_abnormal_gallbladder_physiolo | 1.45729744 |
| 43 | MP0008872_abnormal_physiological_respon | 1.45229691 |
| 44 | MP0003195_calcinosis | 1.45203290 |
| 45 | MP0001664_abnormal_digestion | 1.41509471 |
| 46 | MP0010678_abnormal_skin_adnexa | 1.39650192 |
| 47 | MP0002653_abnormal_ependyma_morphology | 1.38212229 |
| 48 | MP0008569_lethality_at_weaning | 1.38190210 |
| 49 | MP0003075_altered_response_to | 1.37439523 |
| 50 | MP0002837_dystrophic_cardiac_calcinosis | 1.37400380 |
| 51 | MP0002938_white_spotting | 1.37241266 |
| 52 | * MP0000026_abnormal_inner_ear | 1.35885212 |
| 53 | MP0001666_abnormal_nutrient_absorption | 1.35519921 |
| 54 | MP0004264_abnormal_extraembryonic_tissu | 1.34922723 |
| 55 | * MP0001963_abnormal_hearing_physiology | 1.32328242 |
| 56 | MP0003890_abnormal_embryonic-extraembry | 1.32183166 |
| 57 | MP0002295_abnormal_pulmonary_circulatio | 1.31694764 |
| 58 | MP0003011_delayed_dark_adaptation | 1.31103892 |
| 59 | MP0002063_abnormal_learning/memory/cond | 1.30980186 |
| 60 | MP0008961_abnormal_basal_metabolism | 1.29883830 |
| 61 | MP0003252_abnormal_bile_duct | 1.29775010 |
| 62 | MP0001177_atelectasis | 1.29701722 |
| 63 | MP0005377_hearing/vestibular/ear_phenot | 1.28176470 |
| 64 | MP0003878_abnormal_ear_physiology | 1.28176470 |
| 65 | MP0004270_analgesia | 1.27330537 |
| 66 | MP0000049_abnormal_middle_ear | 1.26967274 |
| 67 | MP0002735_abnormal_chemical_nociception | 1.25613074 |
| 68 | MP0002234_abnormal_pharynx_morphology | 1.25040775 |
| 69 | MP0009745_abnormal_behavioral_response | 1.24694225 |
| 70 | MP0008877_abnormal_DNA_methylation | 1.24259989 |
| 71 | MP0002638_abnormal_pupillary_reflex | 1.24226546 |
| 72 | MP0000230_abnormal_systemic_arterial | 1.23618860 |
| 73 | MP0005166_decreased_susceptibility_to | 1.22189490 |
| 74 | MP0003879_abnormal_hair_cell | 1.21473357 |
| 75 | * MP0004885_abnormal_endolymph | 1.21375216 |
| 76 | MP0000569_abnormal_digit_pigmentation | 1.18553551 |
| 77 | MP0004484_altered_response_of | 1.17248946 |
| 78 | MP0005083_abnormal_biliary_tract | 1.17082002 |
| 79 | MP0009046_muscle_twitch | 1.16661407 |
| 80 | MP0001501_abnormal_sleep_pattern | 1.11655075 |
| 81 | MP0002102_abnormal_ear_morphology | 1.09955250 |
| 82 | MP0008004_abnormal_stomach_pH | 1.09286744 |
| 83 | MP0001984_abnormal_olfaction | 1.08871422 |
| 84 | MP0004134_abnormal_chest_morphology | 1.07246377 |
| 85 | MP0005365_abnormal_bile_salt | 1.06711709 |
| 86 | MP0008995_early_reproductive_senescence | 1.06343230 |
| 87 | MP0002064_seizures | 1.06199348 |
| 88 | MP0002876_abnormal_thyroid_physiology | 1.02219223 |
| 89 | MP0003045_fibrosis | 1.02000488 |
| 90 | MP0001486_abnormal_startle_reflex | 1.01182818 |
| 91 | MP0003191_abnormal_cellular_cholesterol | 1.01002017 |
| 92 | MP0005253_abnormal_eye_physiology | 1.00913611 |
| 93 | MP0004147_increased_porphyrin_level | 1.00373051 |
| 94 | MP0006072_abnormal_retinal_apoptosis | 0.99802377 |
| 95 | MP0005319_abnormal_enzyme/_coenzyme | 0.99111839 |
| 96 | MP0002736_abnormal_nociception_after | 0.98825957 |
| 97 | MP0004272_abnormal_basement_membrane | 0.98184123 |
| 98 | MP0003953_abnormal_hormone_level | 0.97816557 |
| 99 | MP0000566_synostosis | 0.97244763 |
| 100 | MP0006292_abnormal_olfactory_placode | 0.97018661 |
| 101 | MP0001970_abnormal_pain_threshold | 0.93555289 |
| 102 | MP0009250_abnormal_appendicular_skeleto | 0.90617273 |
| 103 | MP0005645_abnormal_hypothalamus_physiol | 0.90122311 |
| 104 | MP0010368_abnormal_lymphatic_system | 0.89812694 |
| 105 | MP0002160_abnormal_reproductive_system | 0.89603760 |
| 106 | MP0003638_abnormal_response/metabolism_ | 0.88813318 |
| 107 | MP0002133_abnormal_respiratory_system | 0.88685603 |
| 108 | MP0005388_respiratory_system_phenotype | 0.88685603 |
| 109 | MP0005165_increased_susceptibility_to | 0.87743090 |
| 110 | MP0001968_abnormal_touch/_nociception | 0.87725841 |
| 111 | MP0005389_reproductive_system_phenotype | 0.87188848 |
| 112 | MP0003136_yellow_coat_color | 0.87028466 |
| 113 | MP0002168_other_aberrant_phenotype | 0.86892907 |
| 114 | MP0005174_abnormal_tail_pigmentation | 0.86583337 |
| 115 | MP0005595_abnormal_vascular_smooth | 0.85980839 |
| 116 | MP0002734_abnormal_mechanical_nocicepti | 0.83513871 |
| 117 | MP0003937_abnormal_limbs/digits/tail_de | 0.83512130 |
| 118 | MP0004130_abnormal_muscle_cell | 0.82957728 |
| 119 | MP0002254_reproductive_system_inflammat | 0.82730741 |
| 120 | MP0000534_abnormal_ureter_morphology | 0.82367211 |
| 121 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.82331415 |
| 122 | MP0002572_abnormal_emotion/affect_behav | 0.81816450 |
| 123 | MP0004145_abnormal_muscle_electrophysio | 0.81421729 |
| 124 | MP0000427_abnormal_hair_cycle | 0.80895299 |
| 125 | MP0002067_abnormal_sensory_capabilities | 0.80487933 |
| 126 | MP0001986_abnormal_taste_sensitivity | 0.80301616 |
| 127 | MP0003283_abnormal_digestive_organ | 0.79151968 |
| 128 | MP0003137_abnormal_impulse_conducting | 0.78475729 |
| 129 | MP0006276_abnormal_autonomic_nervous | 0.78284496 |
| 130 | MP0002135_abnormal_kidney_morphology | 0.78088770 |
| 131 | * MP0004742_abnormal_vestibular_system | 0.76759404 |
| 132 | MP0000678_abnormal_parathyroid_gland | 0.76456794 |
| 133 | MP0000681_abnormal_thyroid_gland | 0.74428995 |
| 134 | MP0000778_abnormal_nervous_system | 0.73715748 |
| 135 | MP0002184_abnormal_innervation | 0.73422934 |
| 136 | MP0005171_absent_coat_pigmentation | 0.72156933 |
| 137 | MP0001905_abnormal_dopamine_level | 0.71666098 |
| 138 | MP0002118_abnormal_lipid_homeostasis | 0.71637587 |
| 139 | * MP0002752_abnormal_somatic_nervous | 0.70330737 |
| 140 | MP0005535_abnormal_body_temperature | 0.69892077 |
| 141 | MP0004142_abnormal_muscle_tone | 0.68704685 |
| 142 | MP0003868_abnormal_feces_composition | 0.68279090 |
| 143 | MP0003787_abnormal_imprinting | 0.67909020 |
| 144 | MP0005386_behavior/neurological_phenoty | 0.67861371 |
| 145 | MP0004924_abnormal_behavior | 0.67861371 |
| 146 | * MP0002229_neurodegeneration | 0.67654996 |
| 147 | MP0001919_abnormal_reproductive_system | 0.66605902 |
| 148 | MP0005647_abnormal_sex_gland | 0.65658156 |
| 149 | MP0005075_abnormal_melanosome_morpholog | 0.64752601 |
| 150 | MP0000747_muscle_weakness | 0.62082848 |
| 151 | MP0002733_abnormal_thermal_nociception | 0.61807420 |
| 152 | MP0006138_congestive_heart_failure | 0.60801484 |
| 153 | MP0005084_abnormal_gallbladder_morpholo | 0.59664924 |
| 154 | MP0002557_abnormal_social/conspecific_i | 0.59415349 |
| 155 | MP0005501_abnormal_skin_physiology | 0.58353086 |
| 156 | MP0005187_abnormal_penis_morphology | 0.58331959 |
| 157 | MP0002928_abnormal_bile_duct | 0.57137472 |
| 158 | MP0002896_abnormal_bone_mineralization | 0.56362787 |
| 159 | MP0003115_abnormal_respiratory_system | 0.55779478 |
| 160 | MP0005275_abnormal_skin_tensile | 0.55629435 |
| 161 | MP0001502_abnormal_circadian_rhythm | 0.54890720 |
| 162 | MP0009764_decreased_sensitivity_to | 0.54772803 |
| 163 | MP0005381_digestive/alimentary_phenotyp | 0.53297037 |
| 164 | MP0001663_abnormal_digestive_system | 0.52983454 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperactive renin-angiotensin system (HP:0000841) | 7.61459209 |
| 2 | Gout (HP:0001997) | 7.17583652 |
| 3 | Increased circulating renin level (HP:0000848) | 6.56471173 |
| 4 | Small epiphyses (HP:0010585) | 6.16794041 |
| 5 | * Aplasia/Hypoplasia of the abdominal wall musculature (HP:0010318) | 6.15453903 |
| 6 | Hypokalemic alkalosis (HP:0001949) | 6.10193791 |
| 7 | Abnormality of chloride homeostasis (HP:0011422) | 5.92041195 |
| 8 | Pili torti (HP:0003777) | 5.91886959 |
| 9 | Hypomagnesemia (HP:0002917) | 5.73719151 |
| 10 | Metabolic alkalosis (HP:0200114) | 5.70875081 |
| 11 | Hypothermia (HP:0002045) | 5.52107518 |
| 12 | Hyperthyroidism (HP:0000836) | 5.42461246 |
| 13 | Renal salt wasting (HP:0000127) | 5.10970602 |
| 14 | Abnormality of renal excretion (HP:0011036) | 5.07974940 |
| 15 | Abnormality of renin-angiotensin system (HP:0000847) | 4.90619671 |
| 16 | Abnormality of magnesium homeostasis (HP:0004921) | 4.82576921 |
| 17 | Abnormal urine output (HP:0012590) | 4.78946541 |
| 18 | Polyuria (HP:0000103) | 4.78823307 |
| 19 | Hyperaldosteronism (HP:0000859) | 4.62890806 |
| 20 | Increased purine levels (HP:0004368) | 4.50735931 |
| 21 | Hyperuricemia (HP:0002149) | 4.50735931 |
| 22 | Tetany (HP:0001281) | 4.14762799 |
| 23 | Irregular epiphyses (HP:0010582) | 4.14310233 |
| 24 | Delayed epiphyseal ossification (HP:0002663) | 4.11904801 |
| 25 | Polydipsia (HP:0001959) | 3.98563047 |
| 26 | Abnormal drinking behavior (HP:0030082) | 3.98563047 |
| 27 | Alkalosis (HP:0001948) | 3.92893653 |
| 28 | Abnormal hair laboratory examination (HP:0003328) | 3.77082957 |
| 29 | Abnormality of purine metabolism (HP:0004352) | 3.73637760 |
| 30 | Pancreatic cysts (HP:0001737) | 3.64607835 |
| 31 | Interstitial pulmonary disease (HP:0006530) | 3.54697658 |
| 32 | Pancreatic fibrosis (HP:0100732) | 3.47862305 |
| 33 | True hermaphroditism (HP:0010459) | 3.36332033 |
| 34 | Hyperglycinuria (HP:0003108) | 3.27371518 |
| 35 | Mild short stature (HP:0003502) | 3.25859580 |
| 36 | * Hypothyroidism (HP:0000821) | 3.24041843 |
| 37 | Tubulointerstitial fibrosis (HP:0005576) | 3.23882124 |
| 38 | Proximal tubulopathy (HP:0000114) | 3.22850861 |
| 39 | Epiphyseal dysplasia (HP:0002656) | 3.17059953 |
| 40 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.16827478 |
| 41 | Hypokalemia (HP:0002900) | 3.15090241 |
| 42 | Decreased circulating renin level (HP:0003351) | 3.14362973 |
| 43 | Abnormality of midbrain morphology (HP:0002418) | 3.11095734 |
| 44 | Molar tooth sign on MRI (HP:0002419) | 3.11095734 |
| 45 | Hyperpituitarism (HP:0010514) | 3.07317816 |
| 46 | Abnormality of potassium homeostasis (HP:0011042) | 2.96016201 |
| 47 | Potter facies (HP:0002009) | 2.91683701 |
| 48 | Facial shape deformation (HP:0011334) | 2.91683701 |
| 49 | Congenital stationary night blindness (HP:0007642) | 2.87581432 |
| 50 | Hypercalciuria (HP:0002150) | 2.83913209 |
| 51 | Nephronophthisis (HP:0000090) | 2.82027630 |
| 52 | * Congenital sensorineural hearing impairment (HP:0008527) | 2.81949697 |
| 53 | Aplasia involving bones of the extremities (HP:0009825) | 2.66149588 |
| 54 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.66149588 |
| 55 | Aplasia of the phalanges of the hand (HP:0009802) | 2.66149588 |
| 56 | * Coarse facial features (HP:0000280) | 2.65251506 |
| 57 | Tachypnea (HP:0002789) | 2.64534743 |
| 58 | Glomerulosclerosis (HP:0000096) | 2.60161046 |
| 59 | Macroglossia (HP:0000158) | 2.59727952 |
| 60 | Hyponatremia (HP:0002902) | 2.57811193 |
| 61 | Hypotension (HP:0002615) | 2.57675659 |
| 62 | Abnormality of glycine metabolism (HP:0010895) | 2.56575882 |
| 63 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.56575882 |
| 64 | Abnormality of the renal cortex (HP:0011035) | 2.55265189 |
| 65 | Vacuolated lymphocytes (HP:0001922) | 2.54148143 |
| 66 | Hyperkalemia (HP:0002153) | 2.53274456 |
| 67 | Abolished electroretinogram (ERG) (HP:0000550) | 2.52890434 |
| 68 | Abnormality of sodium homeostasis (HP:0010931) | 2.51985241 |
| 69 | Dehydration (HP:0001944) | 2.51516090 |
| 70 | Ketoacidosis (HP:0001993) | 2.50545000 |
| 71 | Focal motor seizures (HP:0011153) | 2.48028062 |
| 72 | Malnutrition (HP:0004395) | 2.47421571 |
| 73 | Adrenal overactivity (HP:0002717) | 2.43041011 |
| 74 | Type II lissencephaly (HP:0007260) | 2.38552629 |
| 75 | Abnormality of the renal medulla (HP:0100957) | 2.38442944 |
| 76 | Large for gestational age (HP:0001520) | 2.38377714 |
| 77 | Abnormality of nucleobase metabolism (HP:0010932) | 2.36828532 |
| 78 | Onycholysis (HP:0001806) | 2.36313509 |
| 79 | Widely patent fontanelles and sutures (HP:0004492) | 2.36230878 |
| 80 | Vascular calcification (HP:0004934) | 2.31755045 |
| 81 | Hyperventilation (HP:0002883) | 2.29819468 |
| 82 | Hypoplasia of the uterus (HP:0000013) | 2.29589040 |
| 83 | Cystic liver disease (HP:0006706) | 2.28395947 |
| 84 | Keratoconus (HP:0000563) | 2.27930771 |
| 85 | Increased corneal curvature (HP:0100692) | 2.27930771 |
| 86 | Renal tubular acidosis (HP:0001947) | 2.25770214 |
| 87 | Pendular nystagmus (HP:0012043) | 2.24385244 |
| 88 | Cerebral inclusion bodies (HP:0100314) | 2.23676772 |
| 89 | Agitation (HP:0000713) | 2.22500540 |
| 90 | Medial flaring of the eyebrow (HP:0010747) | 2.22119759 |
| 91 | Genetic anticipation (HP:0003743) | 2.21992405 |
| 92 | Abnormality of proline metabolism (HP:0010907) | 2.18099799 |
| 93 | Hydroxyprolinuria (HP:0003080) | 2.18099799 |
| 94 | Congenital, generalized hypertrichosis (HP:0004540) | 2.16288161 |
| 95 | Generalized aminoaciduria (HP:0002909) | 2.15829030 |
| 96 | Abnormality of the vitreous humor (HP:0004327) | 2.15670483 |
| 97 | Tubular atrophy (HP:0000092) | 2.13627138 |
| 98 | * Constipation (HP:0002019) | 2.12278029 |
| 99 | Chronic hepatic failure (HP:0100626) | 2.11448638 |
| 100 | Nephrolithiasis (HP:0000787) | 2.11111577 |
| 101 | Ketosis (HP:0001946) | 2.08901929 |
| 102 | Cardiovascular calcification (HP:0011915) | 2.08102404 |
| 103 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.04869918 |
| 104 | Furrowed tongue (HP:0000221) | 2.04566730 |
| 105 | Genu varum (HP:0002970) | 2.04255400 |
| 106 | Ventricular fibrillation (HP:0001663) | 2.03444199 |
| 107 | Hypoplastic nipples (HP:0002557) | 2.02549502 |
| 108 | Hyperglycinemia (HP:0002154) | 2.02155963 |
| 109 | Abnormality of urine glucose concentration (HP:0011016) | 2.02125902 |
| 110 | Glycosuria (HP:0003076) | 2.02125902 |
| 111 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.00358151 |
| 112 | Mucopolysacchariduria (HP:0008155) | 2.00358151 |
| 113 | Thyroid-stimulating hormone excess (HP:0002925) | 12.2035913 |
| 114 | * Goiter (HP:0000853) | 11.0359901 |
| 115 | Tubulointerstitial abnormality (HP:0001969) | 1.99595193 |
| 116 | Gaze-evoked nystagmus (HP:0000640) | 1.99161752 |
| 117 | Renal cortical cysts (HP:0000803) | 1.99031614 |
| 118 | Lymphangioma (HP:0100764) | 1.97672047 |
| 119 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.97427284 |
| 120 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.97427284 |
| 121 | Decreased central vision (HP:0007663) | 1.96941727 |
| 122 | Nephrocalcinosis (HP:0000121) | 1.94906446 |
| 123 | Progressive cerebellar ataxia (HP:0002073) | 1.94485959 |
| 124 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.93204126 |
| 125 | Attenuation of retinal blood vessels (HP:0007843) | 1.93080690 |
| 126 | Humeroradial synostosis (HP:0003041) | 1.92496459 |
| 127 | Synostosis involving the elbow (HP:0003938) | 1.92496459 |
| 128 | Confusion (HP:0001289) | 1.91476795 |
| 129 | * Thyroid carcinoma (HP:0002890) | 1.90725304 |
| 130 | Gait imbalance (HP:0002141) | 1.90005398 |
| 131 | Dysostosis multiplex (HP:0000943) | 1.89608038 |
| 132 | Chorioretinal atrophy (HP:0000533) | 1.85733009 |
| 133 | Hyperphosphatemia (HP:0002905) | 1.84801673 |
| 134 | 3-Methylglutaconic aciduria (HP:0003535) | 1.84710812 |
| 135 | Neurofibrillary tangles (HP:0002185) | 1.84195258 |
| 136 | Umbilical hernia (HP:0001537) | 1.81875030 |
| 137 | Focal segmental glomerulosclerosis (HP:0000097) | 1.81634320 |
| 138 | Congenital primary aphakia (HP:0007707) | 1.81608983 |
| 139 | Inability to walk (HP:0002540) | 1.81389742 |
| 140 | Hyperphosphaturia (HP:0003109) | 1.79092586 |
| 141 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.79013262 |
| 142 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.79013262 |
| 143 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.79013262 |
| 144 | Sensorimotor neuropathy (HP:0007141) | 1.77672869 |
| 145 | Sclerocornea (HP:0000647) | 1.76916663 |
| 146 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.76324944 |
| 147 | Rickets (HP:0002748) | 1.75669107 |
| 148 | Abnormality of the lower motor neuron (HP:0002366) | 1.73254142 |
| 149 | Absent/shortened dynein arms (HP:0200106) | 1.73228148 |
| 150 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.73228148 |
| 151 | Concave nail (HP:0001598) | 1.72910517 |
| 152 | Male pseudohermaphroditism (HP:0000037) | 1.72214087 |
| 153 | Abnormal urine phosphate concentration (HP:0012599) | 1.71429061 |
| 154 | Hypophosphatemia (HP:0002148) | 1.69903861 |
| 155 | Protuberant abdomen (HP:0001538) | 1.68949569 |
| 156 | Anencephaly (HP:0002323) | 1.68007973 |
| 157 | Steatorrhea (HP:0002570) | 1.67803179 |
| 158 | Genital tract atresia (HP:0001827) | 1.67438147 |
| 159 | Bicornuate uterus (HP:0000813) | 1.67065841 |
| 160 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.65734769 |
| 161 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.65669348 |
| 162 | Focal seizures (HP:0007359) | 1.65544430 |
| 163 | Long toe (HP:0010511) | 1.64396264 |
| 164 | Congenital hepatic fibrosis (HP:0002612) | 1.64184642 |
| 165 | Vaginal atresia (HP:0000148) | 1.62384916 |
| 166 | Hyperalaninemia (HP:0003348) | 1.62326343 |
| 167 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.62326343 |
| 168 | Abnormality of alanine metabolism (HP:0010916) | 1.62326343 |
| 169 | Asplenia (HP:0001746) | 1.61826214 |
| 170 | Bradycardia (HP:0001662) | 1.60587746 |
| 171 | Prolonged QT interval (HP:0001657) | 1.60123146 |
| 172 | Nephrogenic diabetes insipidus (HP:0009806) | 1.60093898 |
| 173 | Astigmatism (HP:0000483) | 1.59930635 |
| 174 | Visceral angiomatosis (HP:0100761) | 1.59502286 |
| 175 | Polycythemia (HP:0001901) | 1.58676656 |
| 176 | Lethargy (HP:0001254) | 1.58438625 |
| 177 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.57105927 |
| 178 | Chondrocalcinosis (HP:0000934) | 1.56489521 |
| 179 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.56210817 |
| 180 | Abnormal ciliary motility (HP:0012262) | 1.55314072 |
| 181 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.54722828 |
| 182 | Fat malabsorption (HP:0002630) | 1.54585190 |
| 183 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.54133914 |
| 184 | Syncope (HP:0001279) | 1.51120666 |
| 185 | Abnormal biliary tract physiology (HP:0012439) | 1.49122647 |
| 186 | Bile duct proliferation (HP:0001408) | 1.49122647 |
| 187 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.48863424 |
| 188 | Prenatal maternal abnormality (HP:0002686) | 1.48609044 |
| 189 | Postaxial foot polydactyly (HP:0001830) | 1.46335390 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OXSR1 | 5.97274427 |
| 2 | STK39 | 5.73451513 |
| 3 | WNK4 | 5.32154455 |
| 4 | NTRK3 | 3.79124593 |
| 5 | EPHA4 | 3.74316978 |
| 6 | GRK1 | 3.27891253 |
| 7 | ADRBK2 | 3.26533565 |
| 8 | BMPR1B | 3.22321384 |
| 9 | WNK3 | 3.18342573 |
| 10 | PINK1 | 2.96418988 |
| 11 | MAP3K9 | 2.62434172 |
| 12 | INSRR | 2.54956332 |
| 13 | CASK | 2.48311677 |
| 14 | EPHA2 | 2.38394595 |
| 15 | MAP4K2 | 2.37431335 |
| 16 | ZAK | 2.12407450 |
| 17 | MST4 | 2.03959625 |
| 18 | KSR2 | 2.00436753 |
| 19 | LMTK2 | 1.98560125 |
| 20 | RIPK4 | 1.95317055 |
| 21 | ACVR1B | 1.83853205 |
| 22 | TLK1 | 1.79114173 |
| 23 | FER | 1.78997457 |
| 24 | MAP3K2 | 1.70557686 |
| 25 | NUAK1 | 1.61605276 |
| 26 | MAPK13 | 1.53939955 |
| 27 | TIE1 | 1.50606509 |
| 28 | PTK2B | 1.48844529 |
| 29 | MAP3K13 | 1.48168800 |
| 30 | STK38 | 1.39708006 |
| 31 | TXK | 1.36959835 |
| 32 | AKT3 | 1.36543543 |
| 33 | DAPK2 | 1.33223343 |
| 34 | TAF1 | 1.27047967 |
| 35 | NME1 | 1.22356051 |
| 36 | ADRBK1 | 1.21088011 |
| 37 | KSR1 | 1.20691126 |
| 38 | MAPKAPK3 | 1.17519098 |
| 39 | SGK223 | 1.16857435 |
| 40 | SGK494 | 1.16857435 |
| 41 | MST1R | 1.14286232 |
| 42 | ARAF | 1.06198694 |
| 43 | CSNK1G2 | 1.05194267 |
| 44 | NTRK2 | 1.04473135 |
| 45 | NLK | 1.04315074 |
| 46 | DAPK1 | 1.04266998 |
| 47 | TGFBR1 | 1.00774726 |
| 48 | PTK2 | 0.99433222 |
| 49 | MINK1 | 0.97774239 |
| 50 | PRKCE | 0.96681919 |
| 51 | ERN1 | 0.96509218 |
| 52 | TGFBR2 | 0.95114790 |
| 53 | STK38L | 0.94088914 |
| 54 | MAP3K7 | 0.93355897 |
| 55 | MKNK2 | 0.90701752 |
| 56 | FRK | 0.88436149 |
| 57 | WNK1 | 0.88253291 |
| 58 | MAP3K12 | 0.87506282 |
| 59 | BCKDK | 0.84843909 |
| 60 | NTRK1 | 0.84170085 |
| 61 | MARK1 | 0.83118273 |
| 62 | DYRK2 | 0.78744113 |
| 63 | LRRK2 | 0.78692293 |
| 64 | MYLK | 0.75048498 |
| 65 | MAPKAPK5 | 0.73888708 |
| 66 | VRK1 | 0.72718167 |
| 67 | EPHB2 | 0.72477835 |
| 68 | CSNK1A1 | 0.72084441 |
| 69 | CAMKK2 | 0.71398560 |
| 70 | FGFR2 | 0.71355862 |
| 71 | TNIK | 0.71189717 |
| 72 | EPHB1 | 0.71183780 |
| 73 | PDPK1 | 0.70460384 |
| 74 | STK16 | 0.67410281 |
| 75 | EPHA3 | 0.66065364 |
| 76 | CSNK1G1 | 0.65274494 |
| 77 | STK3 | 0.64616815 |
| 78 | PDGFRA | 0.64285709 |
| 79 | RAF1 | 0.63903853 |
| 80 | PRKD2 | 0.63754808 |
| 81 | ILK | 0.63408256 |
| 82 | PKN1 | 0.62981794 |
| 83 | MAP3K1 | 0.62630948 |
| 84 | GRK6 | 0.61895859 |
| 85 | PAK4 | 0.61590177 |
| 86 | BRSK2 | 0.60978333 |
| 87 | TAOK3 | 0.60595797 |
| 88 | SGK3 | 0.59571413 |
| 89 | ERBB3 | 0.59552145 |
| 90 | RIPK1 | 0.59511331 |
| 91 | PDK2 | 0.59413421 |
| 92 | SGK1 | 0.59298636 |
| 93 | MUSK | 0.59034961 |
| 94 | CAMK2B | 0.57429211 |
| 95 | PRKACA | 0.54901097 |
| 96 | GRK5 | 0.54895334 |
| 97 | BMPR2 | 0.53761003 |
| 98 | SGK2 | 0.53435736 |
| 99 | MAP2K7 | 0.53189436 |
| 100 | PDGFRB | 0.52329552 |
| 101 | FGFR4 | 0.51745499 |
| 102 | MAP2K4 | 0.51466270 |
| 103 | PLK2 | 0.50716988 |
| 104 | ERBB2 | 0.50369470 |
| 105 | LATS1 | 0.50339717 |
| 106 | PDK3 | 0.49352806 |
| 107 | PDK4 | 0.49352806 |
| 108 | RPS6KA5 | 0.48714662 |
| 109 | PIK3CA | 0.47127846 |
| 110 | CDK5 | 0.46958708 |
| 111 | TRIM28 | 0.46515893 |
| 112 | CAMK1 | 0.45894974 |
| 113 | CSNK1G3 | 0.45789157 |
| 114 | MAP2K1 | 0.44602714 |
| 115 | PRPF4B | 0.44520173 |
| 116 | CAMK2A | 0.44422860 |
| 117 | FES | 0.43894246 |
| 118 | CAMKK1 | 0.43652647 |
| 119 | PTK6 | 0.43493419 |
| 120 | PRKCG | 0.42683565 |
| 121 | MAPK15 | 0.42647145 |
| 122 | PRKCI | 0.42357976 |
| 123 | CHUK | 0.41816080 |
| 124 | VRK2 | 0.41464049 |
| 125 | PDK1 | 0.40692131 |
| 126 | CCNB1 | 0.40646410 |
| 127 | GSK3A | 0.39940222 |
| 128 | SIK1 | 0.39612238 |
| 129 | IKBKB | 0.39224349 |
| 130 | STK24 | 0.38838688 |
| 131 | STK11 | 0.38739666 |
| 132 | DDR2 | 0.38097176 |
| 133 | DMPK | 0.37315010 |
| 134 | MAP2K6 | 0.37303247 |
| 135 | CSNK1A1L | 0.37164616 |
| 136 | PAK3 | 0.36706780 |
| 137 | FGR | 0.35977918 |
| 138 | PRKCA | 0.35871805 |
| 139 | PRKCQ | 0.35022089 |
| 140 | ROCK2 | 0.34758241 |
| 141 | PRKCZ | 0.34681592 |
| 142 | PNCK | 0.33963153 |
| 143 | PAK6 | 0.33890725 |
| 144 | RET | 0.32786389 |
| 145 | MET | 0.32344532 |
| 146 | MARK2 | 0.32045820 |
| 147 | MAP3K4 | 0.31406901 |
| 148 | MAP2K2 | 0.31263119 |
| 149 | TEC | 0.31255423 |
| 150 | CDK3 | 0.29934163 |
| 151 | DYRK1A | 0.29785464 |
| 152 | LATS2 | 0.29782045 |
| 153 | WEE1 | 0.29450400 |
| 154 | IGF1R | 0.28965735 |
| 155 | PHKG1 | 0.28297300 |
| 156 | PHKG2 | 0.28297300 |
| 157 | SCYL2 | 0.28145751 |
| 158 | CAMK1G | 0.26076266 |
| 159 | TRIB3 | 0.25938565 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.53526758 |
| 2 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.87963367 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.75421123 |
| 4 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 2.60437987 |
| 5 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.56729143 |
| 6 | Mineral absorption_Homo sapiens_hsa04978 | 2.53041925 |
| 7 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.27450890 |
| 8 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.19224733 |
| 9 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.17861781 |
| 10 | Phototransduction_Homo sapiens_hsa04744 | 2.12020020 |
| 11 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.11363790 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 1.95290442 |
| 13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.94050319 |
| 14 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.90284143 |
| 15 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.86240228 |
| 16 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.83109250 |
| 17 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.82569487 |
| 18 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.82549017 |
| 19 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.74223198 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.71995806 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.70226355 |
| 22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.70171202 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.67515019 |
| 24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.63677861 |
| 25 | Long-term potentiation_Homo sapiens_hsa04720 | 1.61048438 |
| 26 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.58688312 |
| 27 | Bile secretion_Homo sapiens_hsa04976 | 1.57218541 |
| 28 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.56927116 |
| 29 | Nicotine addiction_Homo sapiens_hsa05033 | 1.53336430 |
| 30 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.49003871 |
| 31 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.47742490 |
| 32 | Protein export_Homo sapiens_hsa03060 | 1.45416307 |
| 33 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.44068579 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.42987990 |
| 35 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.41435683 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.38495215 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.36451218 |
| 38 | Parkinsons disease_Homo sapiens_hsa05012 | 1.31071672 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.26667763 |
| 40 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.24193291 |
| 41 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.21644717 |
| 42 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.19628276 |
| 43 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.19359491 |
| 44 | Circadian entrainment_Homo sapiens_hsa04713 | 1.12960756 |
| 45 | Renin secretion_Homo sapiens_hsa04924 | 1.12212967 |
| 46 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.12078643 |
| 47 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.07077175 |
| 48 | Peroxisome_Homo sapiens_hsa04146 | 1.06617248 |
| 49 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.01700716 |
| 50 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.01686378 |
| 51 | Alzheimers disease_Homo sapiens_hsa05010 | 1.01123715 |
| 52 | * Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.00975201 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 0.98219268 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.98004954 |
| 55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.97972997 |
| 56 | Basal transcription factors_Homo sapiens_hsa03022 | 0.96926388 |
| 57 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.94166997 |
| 58 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.93962826 |
| 59 | Other glycan degradation_Homo sapiens_hsa00511 | 0.93956462 |
| 60 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.92654727 |
| 61 | Cocaine addiction_Homo sapiens_hsa05030 | 0.91657628 |
| 62 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.91645448 |
| 63 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91588653 |
| 64 | Huntingtons disease_Homo sapiens_hsa05016 | 0.91259405 |
| 65 | Lysosome_Homo sapiens_hsa04142 | 0.90078824 |
| 66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89982986 |
| 67 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.89614727 |
| 68 | Olfactory transduction_Homo sapiens_hsa04740 | 0.88559156 |
| 69 | Taste transduction_Homo sapiens_hsa04742 | 0.87705540 |
| 70 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.87416798 |
| 71 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.86910091 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.86860829 |
| 73 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.85605680 |
| 74 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.84969084 |
| 75 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.84935333 |
| 76 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.83572479 |
| 77 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80130460 |
| 78 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.78716516 |
| 79 | GABAergic synapse_Homo sapiens_hsa04727 | 0.77448199 |
| 80 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.76846469 |
| 81 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.76811286 |
| 82 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.75229465 |
| 83 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.74744723 |
| 84 | Circadian rhythm_Homo sapiens_hsa04710 | 0.74237396 |
| 85 | Histidine metabolism_Homo sapiens_hsa00340 | 0.71219385 |
| 86 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70138062 |
| 87 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.66401589 |
| 88 | Tight junction_Homo sapiens_hsa04530 | 0.64840218 |
| 89 | Insulin secretion_Homo sapiens_hsa04911 | 0.64627088 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64585931 |
| 91 | RNA polymerase_Homo sapiens_hsa03020 | 0.64584815 |
| 92 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.64580022 |
| 93 | Morphine addiction_Homo sapiens_hsa05032 | 0.64562904 |
| 94 | Carbon metabolism_Homo sapiens_hsa01200 | 0.63856027 |
| 95 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.63638376 |
| 96 | Retinol metabolism_Homo sapiens_hsa00830 | 0.62262693 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60754322 |
| 98 | Long-term depression_Homo sapiens_hsa04730 | 0.60712922 |
| 99 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.60338736 |
| 100 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.60016398 |
| 101 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.59189666 |
| 102 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.59131290 |
| 103 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.59010592 |
| 104 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58836148 |
| 105 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.58066270 |
| 106 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.57769695 |
| 107 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.57449976 |
| 108 | Homologous recombination_Homo sapiens_hsa03440 | 0.57235733 |
| 109 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.57184187 |
| 110 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.56322304 |
| 111 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.56273946 |
| 112 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.56178765 |
| 113 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.55266976 |
| 114 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52768489 |
| 115 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.52248724 |
| 116 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.52210697 |
| 117 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.52115356 |
| 118 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52001188 |
| 119 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.51696753 |
| 120 | Gap junction_Homo sapiens_hsa04540 | 0.51589453 |
| 121 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51565071 |
| 122 | Axon guidance_Homo sapiens_hsa04360 | 0.51056712 |
| 123 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.49713910 |
| 124 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48710720 |
| 125 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.48436851 |
| 126 | Glioma_Homo sapiens_hsa05214 | 0.48434416 |
| 127 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48266602 |
| 128 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.47851784 |
| 129 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.47559736 |
| 130 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.47101130 |
| 131 | Melanogenesis_Homo sapiens_hsa04916 | 0.45970835 |
| 132 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.45844760 |
| 133 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45667304 |
| 134 | Bladder cancer_Homo sapiens_hsa05219 | 0.45462073 |
| 135 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.43346563 |
| 136 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.43339279 |
| 137 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.42716762 |
| 138 | Lysine degradation_Homo sapiens_hsa00310 | 0.41109364 |
| 139 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.39952525 |
| 140 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.39121563 |
| 141 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.38576569 |
| 142 | Adherens junction_Homo sapiens_hsa04520 | 0.37884765 |
| 143 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.37127019 |
| 144 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36172640 |
| 145 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.35910313 |
| 146 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.33919096 |
| 147 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33672031 |
| 148 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.30897623 |
| 149 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.30003114 |

